The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis
Open accessAbstract
Oxidative stress is a key feature in the Alzheimer's disease (AD) brain and manifests as lipid peroxidation (LPO). Isoprostanes (iPs) are specific and sensitive markers of in vivo LPO. To determine whether amyloid beta (Abeta) deposition in vivo is associated with increased LPO, we examined iP levels in a transgenic mouse model (Tg2576) of AD amyloidosis. Urine, plasma, and brain tissues were collected from Tg2576 and littermate wild-type (WT) animals at different time points starting at 4 months of age and continuing until 18 months of age. Levels of urinary 8,12-iso-iPF(2alpha)-VI were higher in Tg2576 than in WT animals as early as 8 months of age and remained this high for the rest of the study. A similar pattern was observed for plasma levels of 8,12-iso-iPF(2alpha)-VI. Homogenates from the cerebral cortex and hippocampus of Tg2576 mice had higher levels of 8,12-iso-iPF(2alpha)-VI than those from WT mice starting at 8 months of age. In contrast, a surge of Abeta 1-40 and 1-42 levels as well as Abeta deposits in Tg2576 mouse brains occurred later, at 12 months of age. A direct correlation was observed between brain 8,12-iso-iPF(2alpha)-VI and Abeta 1-40 and 1-42. Because LPO precedes amyloid plaque formation in Tg2576 mice, this suggests that brain oxidative damage contributes to AD pathogenesis before Abeta accumulation in the AD brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Past and recent studies have demonstrated that oxidative damage is not only an early event in the pathogenesis of AD, occurring before the onset of clinical symptoms but also a factor contributing to the disease progression [17,18,19,20,21].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“All of these markers of OS have been described as an early alteration in the AD brain, and this concept has been used in the past to support the ‘oxidative stress hypothesis’ in the pathogenesis of AD [20,28,29,30].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [20]
Experimental — accuracy not yet measuredIn the citing paper
“The pioneering studies, conducted to validate the early changes of products of oxidative damage, found in specimens of AD patients, in a transgenic mouse model (Tg2576) of AD amyloidosis, dated back more than 20 years [20,124].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
The measurement and mechanism of lipid peroxidation in biological systems
Gutteridge, J. M. C., & Halliwell, B. B. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90206-q · Cited by 1,297
Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 4×
“Indeed, the recent demonstration of rare Ab plaques as well as scant amounts of formic acid-extractable Ab in 8-month-old Tg2576 mouse brains prompts cautious interpretation of our data with respect to whether LPO precedes or is linked to the initial stages of AD-like amyloidosis in Tg2576 mice ( Kawarabayashi et al.,…”
BackgroundInfluentialAntioxidants, Oxidative Stress, and Degenerative Neurological Disorders
Floyd, R. A. (1999) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-140.x · Cited by 828
Oxidative Alterations in Alzheimer's Disease
Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 789
Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain
Gravina, S. A., Ho, L., Eckman, C. B., Long, K. E., Otvos, L., Younkin, L. H., Suzuki, N., & Younkin, S. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7013 · Cited by 676
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649
Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress
Smith, M. A., Hirai, K., Hsiao, K., Pappolla, M. A., Harris, P. L. R., Siedlak, S. L., Tabaton, M., & Perry, G. L. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052212.x · Cited by 547
Hsiao, K., Borchelt, D., Olson, K., Johannsdottir, R., Kitt, C. A., Yunis, W. S., Xu, S., Eckman, C., Younkin, S. G., Price, D., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90107-8 · Cited by 527
Yan, S. D., Yan, S. F., Chen, X., Fu, J., Chen, M., Kuppusamy, P., Smith, M. A., Perry, G., Godman, G. C., Nawroth, P., et al. (1995) · Nature Medicine · doi:10.1038/nm0795-693 · Cited by 406
Research works printed but not linked: 1
- Pappolla, 1998, Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease., Am J Pathol, 152, 871
Cited by
Sorted by citations
Items 301–400 of 776
Han, J. H., Lee, Y. S., Im, J. H., Ham, Y. W., Lee, H. P., Han, S., & Hong, J. T. (2019) · Marine Drugs · doi:10.3390/md17020123 · Cited by 76
ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer’s Disease
Patro, S., Ratna, S., Yamamoto, H. A., Ebenezer, A. T., Ferguson, D. S., Kaur, A., McIntyre, B. C., Snow, R., & Solesio, M. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011185 · Cited by 76
Ye, J., Meng, X., Yan, C., & Wang, C. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0063-0 · Cited by 74
Leskovjan, A. C., Kretlow, A., & Miller, L. M. (2010) · Analytical Chemistry · doi:10.1021/ac1002728 · Cited by 77
Red cell perturbations by amyloid β-protein
Rajadas, J., Kusiak, J. W., Chrest, F. J., Demehin, A. A., Jayaraman, M., Wersto, R. P., Nagababu, E., Ravi, L. B., & Rifkind, J. M. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(03)00101-6 · Cited by 74
Dumont, M., Ho, D. J., Calingasan, N. Y., Xu, H., Gibson, G. E., & Beal, M. F. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.008 · Cited by 73
Shen, L., Chen, C., Yang, A., Chen, Y., Liu, Q., & Ni, J. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.04.005 · Cited by 73
Amelioration of the Alzheimer's Disease Phenotype by Absence of 12/15-Lipoxygenase
Yang, H., Zhuo, J., Chu, J., Chinnici, C. M., & Praticò, D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.010 · Cited by 75
Self-citationToxic Role of K+Channel Oxidation in Mammalian Brain
Cotella, D., Hernández-Enríquez, B., Wu, X., Li, R., Pan, Z., Leveille, J., Link, C. D., Oddo, S., & Sesti, F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6153-11.2012 · Cited by 76
Farr, S. A., Erickson, M. A., Niehoff, M. L., Banks, W. A., & Morley, J. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131883 · Cited by 72
Stojakovic, A., Trushin, S., Sheu, A., Khalili, L., Chang, S.-Y., Li, X., Christensen, T., Salisbury, J. L., Geroux, R. E., Gateno, B., et al. (2021) · Communications Biology · doi:10.1038/s42003-020-01584-y · Cited by 72
Presenilin-1 adopts pathogenic conformation in normal aging and in sporadic Alzheimer’s disease
Wahlster, L., Arimon, M., Nasser‐Ghodsi, N., Post, K. L., Serrano‐Pozo, A., Uemura, K., & Berezovska, O. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1065-6 · Cited by 72
Talwar, P., Sinha, J., Grover, S., Rawat, C., Kushwaha, S. S., Agarwal, R., Taneja, V., & Kukreti, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9390-0 · Cited by 71
Antioxidant protection and neurodegenerative disease: The role of amyloid-β and tau
Castellani, R. J., Lee, H., Perry, G. L., & Smith, M. A. (2006) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750602100213 · Cited by 72
Montiel, T., Quiroz‐Baez, R., Massieu, L., & Arias, C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.126 · Cited by 70
Calingasan, N. Y., Ho, D. J., Wille, E. J., Campagna, M. V., Ruan, J., Dumont, M., Yang, L., Shi, Q., Gibson, G. E., & Beal, M. F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.071 · Cited by 69
Cimini, A., Moreno, S., D’Amelio, M., Cristiano, L., D’Angelo, B., Falone, S., Benedetti, E., Carrara, P., Fanelli, F., Cecconi, F., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1199 · Cited by 70
Protective effects of different exercise modalities in an Alzheimer’s disease-like model
Özbeyli, D., Sarı, G., Özkan, N., Karademir-Yilmaz, B., Yüksel, M., Çilingir‐Kaya, Ö. T., & ÇAKIR, Ö. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.03.044 · Cited by 68
Peptides as Potential Therapeutics for Alzheimer’s Disease
Ribarič, S. (2018) · Molecules · doi:10.3390/molecules23020283 · Cited by 69
Amyloid-β25–35 impairs memory and increases NO in the temporal cortex of rats
Limón, I. D., Díaz, A., Mendieta, L., Chamorro, G., Espinosa, B., Zenteno, E., & Guevara, J. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.11.006 · Cited by 68
Alzheimer’s Disease Risk Genes and Lipid Regulators
Gaamouch, F. E., Jing, P., Xia, J., & Cai, D. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160169 · Cited by 67
Daroi, P. A., Dhage, S. N., & Juvekar, A. R. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab077 · Cited by 66
Oxidative Stress and Neuronal Adaptation in Alzheimer Disease: The Role of SAPK Pathways
Zhu, X., Raina, A. K., Lee, H., Chao, M. P., Nunomura, A., Tabaton, M., Petersen, R. B., Perry, G. L., & Smith, M. A. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603770310220 · Cited by 67
Formaldehyde and Brain Disorders: A Meta-Analysis and Bioinformatics Approach
Rana, I., Rieswijk, L., Steinmaus, C., & Zhang, L. (2021) · Neurotoxicity Research · doi:10.1007/s12640-020-00320-y · Cited by 67
The neurobiology of isoprostanes and Alzheimer's disease
Praticò, D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.01.009 · Cited by 65
Self-citationPreventive effects of Chlorella on cognitive decline in age-dependent dementia model mice
Nakashima, Y., Ohsawa, I., Konishi, F., Hasegawa, T., Kumamoto, S., Suzuki, Y., & Ohta, S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.044 · Cited by 66
Iron Pathophysiology in Alzheimer’s Diseases
Wang, T., Xu, S.-F., Fan, Y.-G., Li, L.-B., & Guo, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_5 · Cited by 64
Cilleros-Holgado, P., Gómez-Fernández, D., Piñero-Pérez, R., Romero-Domínguez, J. M., Reche-López, D., López-Cabrera, A., Álvarez-Córdoba, M., Munuera-Cabeza, M., Talaverón-Rey, M., Suárez-Carrillo, A., et al. (2023) · Biomolecules · doi:10.3390/biom13121789 · Cited by 68
Kuo, Y., Lin, C.-Y., Li, J., & Lou, Y.-I. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s128396 · Cited by 64
The Role of Eicosanoids in Alzheimer’s Disease
Biringer, R. G. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16142560 · Cited by 65
Facheris, M., Beretta, S., & Ferrarese, C. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6210 · Cited by 61
Perspectives on the Amyloid-β Cascade Hypothesis
Lee, H., Casadesús, G., Zhu, X., Joseph, J. A., Perry, G. L., & Smith, M. A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6205 · Cited by 66
Gibson, G. E. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00802-x · Cited by 65
Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer s disease
Gibson, G. E. (2002) · Frontiers in bioscience · doi:10.2741/a827 · Cited by 63
Gallagher, J. J., Finnegan, M. E., Grehan, B., Dobson, J., Collingwood, J. F., & Lynch, M. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110614 · Cited by 64
Early Onset Alzheimer’s Disease and Oxidative Stress
Meraz‐Ríos, M. A., Franco-Bocanegra, D., Toral-Ríos, D., & Campos‐Peña, V. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/375968 · Cited by 65
Cervellati, C., Romani, A., Seripa, D., Cremonini, E., Bosi, C., Magon, S., Bergamini, C. M., Valacchi, G., Pilotto, A., & Zuliani, G. (2014) · BioMed Research International · doi:10.1155/2014/309507 · Cited by 63
Palavicini, J. P., Wang, C., Chen, L., HoSang, K. M., Wang, J., Tomiyama, T., Mori, H., & Han, X. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0460-6 · Cited by 62
Local and systemic increase in lipid peroxidation after moderate experimental traumatic brain injury
Praticò, D., Reiss, P., Tang, L. X., Sung, S., Rokach, J., & McIntosh, T. K. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00777.x · Cited by 63
Self-citationStrategies, Development, and Pitfalls of Therapeutic Options for Alzheimer's Disease
Haas, C. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110986 · Cited by 61
Ntsapi, C., & Loos, B. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.07.014 · Cited by 65
Chiang, G. C.-Y., Mao, X., Kang, G., Chang, E., Pandya, S., Vallabhajosula, S., Isaacson, R., Ravdin, L., Initiative, A. D. N., & Shungu, D. C. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5143 · Cited by 62
Guan, Z.-Z. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00819.x · Cited by 61
Sleep and circadian rhythm disruption and stress intersect in Alzheimer's disease
Phan, T., & Malkani, R. G. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.10.001 · Cited by 66
Amyloid‐β in Alzheimer's disease: the horse or the cart? Pathogenic or protective?
Lee, H., Castellani, R. J., Zhu, X., Perry, G. L., & Smith, M. A. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00429.x · Cited by 66
Lee, H. P., Pancholi, N., Esposito, L., Previll, L. A., Wang, X., Zhu, X., Smith, M. A., & Lee, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028033 · Cited by 61
Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal
Pugazhenthi, S., Phansalkar, K., Audesirk, G. J., West, A. E., & Cabell, L. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.023 · Cited by 59
Sun, K.-H., Lee, H., Smith, M. A., & Shah, K. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-05-0433 · Cited by 59
Lecanu, L., Greeson, J., & Papadopoulos, V. (2005) · Pharmacology · doi:10.1159/000088929 · Cited by 58
Chakrabarti, M., McDonald, A. J., Will Reed, J., Moss, M. A., Das, B. C., & Ray, S. K. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150450 · Cited by 57
Liu, M., Guo, H. W., Li, Z., Zhang, C., Zhang, X., Cui, Q., & Tian, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.601603 · Cited by 57
Cobalamin deficiency, hyperhomocysteinemia, and dementia
Werder (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6564 · Cited by 57
Koivisto, H., Grimm, M. O. W., Rothhaar, T. L., Berkecz, R., Lütjohann, D., Giniatullina, R., Takalo, M., Miettinen, P. O., Lahtinen, H.-M., Giniatullin, R. A., et al. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.09.015 · Cited by 57
The Antioxidant Effects of Thymoquinone in Activated BV-2 Murine Microglial Cells
Cobourne-Duval, M. K., Taka, E., Mendonca, P., Bauer, D., & Soliman, K. F. A. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2047-1 · Cited by 56
Jeon, S., Bose, S., Hur, J., Jun, K.-Y., Kim, Y., Cho, K. S., & Koo, B. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.06.046 · Cited by 57
RETRACTED: Decrypting the potential role of α-lipoic acid in Alzheimer's disease
Kaur, D., Behl, T., Sehgal, A., Singh, S., Sharma, N., Chigurupati, S., Alhowail, A., Abdeen, A., Ibrahim, S. F., Vargas-De-La-Cruz, C. B., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119899 · Cited by 57
RetractedDaulatzai, M. A. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9407-2 · Cited by 56
Nithianantharajah, J., & Hannan, A. J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.026 · Cited by 58
The Neuroprotective Role of Creatine
Klein, A., & Ferrante, R. J. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6486-9_11 · Cited by 56
Koppaka, V., Paul, C., Murray, I. V. J., & Axelsen, P. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301334200 · Cited by 57
Verma, A., Azhar, G., Zhang, X., Patyal, P., Grishma, K. C., Sharma, S., Che, Y., & Wei, J. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020950 · Cited by 55
Ohsawa, I., Kamino, K., Nagasaka, K., Ando, F., Niino, N., Shimokata, H., & Ohta, S. (2003) · Journal of Human Genetics · doi:10.1007/s10038-003-0046-y · Cited by 55
Alterations in β-amyloid production and deposition in brain regions of two transgenic models
Lehman, E. J. H., Kulnane, L. S., & Lamb, B. T. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00153-7 · Cited by 55
Majerníková, N., den Dunnen, W. F. A., & Dolga, A. M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.745046 · Cited by 56
Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
Castellani, R. J., Zhu, X., Lee, H., Smith, M. A., & Perry, G. L. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10031386 · Cited by 57
Matsumura, A., Emoto, M. C., Suzuki, S., Iwahara, N., Hisahara, S., Kawamata, J., Suzuki, H., Yamauchi, A., Sato‐Akaba, H., Fujii, H. G., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.013 · Cited by 52
Evans, N. A., Facci, L., OWEN, D. E., Soden, P. E., Burbidge, S. A., Prinjha, R. K., Richardson, J. C., & Skaper, S. D. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.08.001 · Cited by 56
Song, W., Zukor, H., Lin, S., Liberman, A., Tavitian, A., Mui, J., Vali, H., Fillebeen, C., Pantopoulos, K., Wu, T., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07914.x · Cited by 56
Oxidative Stress and Its Clinical Applications in Dementia
Mao, P. (2012) · Journal of Neurodegenerative Diseases · doi:10.1155/2013/319898 · Cited by 56
Wang, C., Zhang, Q., Xun, Z., Yuan, L., Li, R., Li, X., Tian, S.-Y., Xin, N., & Xu, Y. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101672 · Cited by 52
Myricetin as a Promising Molecule for the Treatment of Post-Ischemic Brain Neurodegeneration
Pluta, R. M., Januszewski, S., & Czuczwar, S. J. (2021) · Nutrients · doi:10.3390/nu13020342 · Cited by 49
Vuletic, S., Peskind, E. R., Marcovina, S. M., Quinn, J. F., Cheung, M. C., Kennedy, H., Kaye, J. A., Jin, L., & Albers, J. J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20458 · Cited by 43
Protection against β-amyloid induced abnormal synaptic function and cell death by Ginkgolide J
Vitolo, O. V., Gong, B., Cao, Z., Ishii, H., Jaracz, S., Nakanishi, K., Arancio, O., Dzyuba, S. V., Lefort, R., & Shelanski, M. L. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.025 · Cited by 52
Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice
Iacobini, C., Oddi, G., Menini, S., Amadio, L., Ricci, C., Pippo, C. D., Sorcini, M., Pricci, F., Pugliese, F. R., & Pugliese, G. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00435.2004 · Cited by 51
Physiological Antioxidative Network of the Bilirubin System in Aging and Age-Related Diseases
Kim, S. Y., & Park, S. C. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00045 · Cited by 53
Ghouzzi, V. E., Csaba, Z., Olivier, P., Lelouvier, B., Schwendimann, L., Dournaud, P., Verney, C., Rustin, P., & Gressèns, P. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318148b822 · Cited by 53
Craft, J. M., Watterson, D. M., Marks, A., & Eldik, L. J. V. (2005) · Glia · doi:10.1002/glia.20194 · Cited by 50
Belkacemi, A., & Ramassamy, C. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.020 · Cited by 51
Targeting Mitochondrial Bioenergetics for Alzheimers Prevention and Treatment
Yao, J., & Brinton, R. D. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072517 · Cited by 50
Oxidative stress in the brain at early preclinical stages of mouse scrapie
Yun, S., Gerlach, M., Riederer, P. F., & Klein, M. A. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.03.025 · Cited by 52
Kim, H., Bing, G., Jhoo, W., Kim, W.-K., Shin, E., Park, E.-S., Choi, Y.-S., Lee, D., Shin, C. Y., Ryu, J. R., et al. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00382-5 · Cited by 49
Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme
Gibson, G. E., Zhang, H., Xu, H., Park, L. C. H., & Jeitner, T. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00091-6 · Cited by 49
Jones, A., Kulozik, P., Ostertag, A., & Herzig, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0973 · Cited by 47
Mitochondrial DNA Sequence Variation Associated with Dementia and Cognitive Function in the Elderly
Tranah, G. J., The Health, A. A. B. C. S., Nalls, M. A., Katzman, S. M., Yokoyama, J. S., Lam, E. T., Zhao, Y., Mooney, S. D., Thomas, F., Newman, A. B., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120466 · Cited by 50
ReviewGenetics, lifestyle and the roles of amyloid β and oxidative stress in Alzheimer’s disease
Veurink, G., Fuller, S. J., Atwood, C., & Martins, R. N. (2003) · Annals of Human Biology · doi:10.1080/03014460310001620144 · Cited by 47
Adiponectin as a new paradigm for approaching Alzheimer's disease
Song, J., & Lee, J. E. (2013) · Anatomy & Cell Biology · doi:10.5115/acb.2013.46.4.229 · Cited by 48
Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47
Neurobiological aspects of Alzheimer's disease
Chopra, K., Misra, S., & Kuhad, A. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.557363 · Cited by 47
Attia, H., Albuhayri, S., Alaraidh, S., Alotaibi, A., Yacoub, H. I., Mohamad, R. A., & Alamin, M. A. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22519 · Cited by 47
Antioxidants and Alzheimerʼs disease: from bench to bedside (and back again)
Rutten, B. P. F., Steinbusch, H. W. M., Korr, H., & Schmitz, C. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200211000-00006 · Cited by 47
Chronological primacy of oxidative stress in Alzheimer disease
Smith, M. A., Nunomura, A., Lee, H., Zhu, X., Moreira, P. I., Ávila, J., & Perry, G. L. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.021 · Cited by 50
Peng, Q., Zeng, Q., Wang, F., Wu, X., Zhang, R., Shi, G., & Zhang, M. (2023) · ACS Nano · doi:10.1021/acsnano.3c08499 · Cited by 46
Zinc and its effects on oxidative stress in Alzheimer’s disease
Yuan, Y., Niu, F., Liu, Y., & Lu, N. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1668-x · Cited by 47
Platt, T. L., Reeves, V. L., & Murphy, M. P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.017 · Cited by 48
Alzheimer's disease: Is this a brain specific diabetic condition?
Rani, V., Deshmukh, R. R., Jaswal, P., Kumar, P., & Bariwal, J. B. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.05.041 · Cited by 46
Leading the way in the nervous system: Lipid Droplets as new players in health and disease
Teixeira, V., Maciel, P., & Costa, V. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158820 · Cited by 46
Bobich, J. A., Zheng, Q., & Campbell, A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6305 · Cited by 46
Peuchant, E., Richard‐Harston, S., Bourdel‐Marchasson, I., Dartigues, J., Letenneur, L., Barberger‐Gateau, P., Dabernat, S., & Daniel, J. Y. (2008) · Translational research · doi:10.1016/j.trsl.2008.05.009 · Cited by 48
Mechanisms of Mitochondrial Malfunction in Alzheimer’s Disease: New Therapeutic Hope
Nabi, S. U., Khan, A., Siddiqui, E. M., Rehman, M. U., Alshahrani, S., Arafah, A. M., Mehan, S., Alsaffar, R. M., Alexiou, A. T., & Shen, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4759963 · Cited by 51
Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities
Pal, A., Cerchiaro, G., Rani, I., Ventriglia, M., Rongioletti, M. C. A., Longobardi, A., & Squitti, R. (2022) · Biomolecules · doi:10.3390/biom12091248 · Cited by 49
Metadata
- Authors
- Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y.
- Affiliations
- University of Pennsylvania (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2001-06-15
- Volume
- 21
- Issue
- 12
- Pages
- 4183-4187
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6762743
- OpenAlex
- W1954454186
- Cited by
- 777
- References
- 24
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 17 · 2023: 29 · 2022: 19 · 2021: 32 · 2020: 23 · 2019: 27 · 2018: 16 · 2017: 24 · 2016: 24 · 2015: 28 · 2014: 32 · 2013: 37 · 2012: 48
- FWCI
- 22.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health (AG-11542)
- National Institute on Aging (P01AG011542, AG 11542)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- lipid peroxidation, isoprostanes, amyloid-beta, amyloid plaques, Alzheimer's disease, Tg2576 mice, oxidative stress, Aβ40, amyloid-beta 42, brain oxidative damage, pathogenesis
- MeSH terms
- Aging, Alzheimer Disease, Amyloidosis, Animals, Brain, Cerebellum, Cerebral Cortex, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Female, Hippocampus, Male, Mice, Transgenic, Peptide Fragments, Lipid Peroxidation, Dinoprost, Amyloid beta-Peptides, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review